INR 51.69
(3.44%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 80.5 Million INR | -17.53% |
2022 | 97.61 Million INR | -22.51% |
2021 | 125.97 Million INR | -16.31% |
2020 | 150.52 Million INR | 8.46% |
2019 | 138.78 Million INR | 2.65% |
2018 | 135.19 Million INR | 7.47% |
2017 | 125.79 Million INR | -34.96% |
2016 | 193.41 Million INR | 40.14% |
2015 | 138.01 Million INR | 74.97% |
2014 | 78.87 Million INR | -6.23% |
2013 | 84.11 Million INR | 50.38% |
2012 | 55.93 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q1 | - INR | -100.0% |
2023 Q2 | 80.91 Million INR | 0.0% |
2023 FY | 80.5 Million INR | -17.53% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 80.5 Million INR | 0.0% |
2022 FY | 97.61 Million INR | -22.51% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 139.21 Million INR | 0.0% |
2022 Q4 | 97.61 Million INR | 0.0% |
2021 Q2 | 108.06 Million INR | 0.0% |
2021 FY | 125.97 Million INR | -16.31% |
2021 Q4 | 125.97 Million INR | 0.0% |
2020 FY | 150.52 Million INR | 8.46% |
2020 Q2 | 141.9 Million INR | 0.0% |
2020 Q1 | 141.9 Million INR | 2.25% |
2020 Q4 | 150.52 Million INR | 0.02% |
2020 Q3 | 150.5 Million INR | 6.06% |
2019 Q4 | 138.78 Million INR | 0.0% |
2019 Q1 | 151.21 Million INR | 11.85% |
2019 Q3 | 138.78 Million INR | -8.22% |
2019 Q2 | 151.21 Million INR | 0.0% |
2019 FY | 138.78 Million INR | 2.65% |
2018 Q4 | 135.19 Million INR | 0.0% |
2018 FY | 135.19 Million INR | 7.47% |
2018 Q3 | 135.19 Million INR | 17.09% |
2018 Q2 | 115.46 Million INR | 0.0% |
2018 Q1 | 115.46 Million INR | -8.21% |
2017 FY | 125.79 Million INR | -34.96% |
2017 Q1 | 190.49 Million INR | -1.51% |
2017 Q2 | 190.48 Million INR | -0.0% |
2017 Q3 | 125.79 Million INR | -33.96% |
2017 Q4 | 125.79 Million INR | 0.0% |
2016 FY | 193.41 Million INR | 40.14% |
2016 Q4 | 193.41 Million INR | 0.0% |
2015 FY | 138.01 Million INR | 74.97% |
2014 FY | 78.87 Million INR | -6.23% |
2013 FY | 84.11 Million INR | 50.38% |
2012 FY | 55.93 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Ajanta Pharma Limited | 352.8 Million INR | 77.181% |
Amrutanjan Health Care Limited | 17.28 Million INR | -365.799% |
Sigachi Industries Limited | 1.43 Billion INR | 94.372% |
Bal Pharma Limited | 1.39 Billion INR | 94.235% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 51.567% |
Lasa Supergenerics Limited | 220.76 Million INR | 63.534% |
Venus Remedies Limited | 413.3 Million INR | 80.522% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 86.835% |
Alpa Laboratories Limited | 52.46 Million INR | -53.443% |
Nectar Lifesciences Limited | 6.35 Billion INR | 98.733% |
Shilpa Medicare Limited | 9.37 Billion INR | 99.141% |
Aarti Drugs Limited | 5.64 Billion INR | 98.573% |
Lupin Limited | 29.21 Billion INR | 99.724% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.879% |
Zydus Lifesciences Limited | 8.04 Billion INR | 98.999% |
Windlas Biotech Limited | 36.41 Million INR | -121.104% |
Suven Life Sciences Limited | 7.09 Million INR | -1034.338% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.711% |
Valiant Laboratories Limited | 767.08 Million INR | 89.505% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 97.868% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.204% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.44% |
Bliss GVS Pharma Limited | 998.4 Million INR | 91.937% |
Achyut Healthcare Limited | - INR | -Infinity% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.754% |
Bajaj HealthCare Limited | 3.32 Billion INR | 97.581% |
RPG Life Sciences Limited | - INR | -Infinity% |
Mankind Pharma Limited | 2.07 Billion INR | 96.114% |
Laurus Labs Limited | 25.77 Billion INR | 99.688% |
Piramal Pharma Limited | 47.1 Billion INR | 99.829% |
Syncom Formulations (India) Limited | 724.86 Million INR | 88.894% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.8% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 98.431% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.346% |
Unichem Laboratories Limited | 2.47 Billion INR | 96.747% |
Sequent Scientific Limited | 4.87 Billion INR | 98.349% |
Novartis India Limited | 69.7 Million INR | -15.501% |
Wanbury Limited | 1.16 Billion INR | 93.089% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 87.614% |
Wockhardt Limited | 23.56 Billion INR | 99.658% |
Themis Medicare Limited | 957.92 Million INR | 91.596% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | 9.961% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.78% |
Glenmark Life Sciences Limited | 171.48 Million INR | 53.053% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.598% |
Divi's Laboratories Limited | 30 Million INR | -168.347% |
NATCO Pharma Limited | 3.71 Billion INR | 97.831% |
Gufic Biosciences Limited | 3.32 Billion INR | 97.582% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 75.426% |
Ind-Swift Limited | 10.13 Billion INR | 99.206% |
Procter & Gamble Health Limited | 95.6 Million INR | 15.791% |
FDC Limited | 205.18 Million INR | 60.765% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 95.838% |
Granules India Limited | 13.15 Billion INR | 99.388% |
Medicamen Biotech Limited | 308.17 Million INR | 73.877% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.432% |
AstraZeneca Pharma India Limited | 45.98 Million INR | -75.077% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -1734.222% |
Brooks Laboratories Limited | 56.41 Million INR | -42.69% |
Megasoft Limited | 1.47 Billion INR | 94.525% |
ZIM Laboratories Limited | 1.08 Billion INR | 92.602% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.68% |
Neuland Laboratories Limited | 953.89 Million INR | 91.561% |
Morepen Laboratories Limited | 289.99 Million INR | 72.239% |
Hikal Limited | 8.17 Billion INR | 99.015% |
Indoco Remedies Limited | 6.71 Billion INR | 98.802% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 97.178% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 74.561% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 91.826% |
Hester Biosciences Limited | 2.44 Billion INR | 96.706% |